INS and metabolic dysfunction-associated steatotic liver disease: Fraterrigo et al. reported similar observations in 9 obese subjects with nonalcoholic fatty liver disease in a small study using a hyperinsulinemic-euglycemic clamp procedure to assess muscle insulin sensitivity before and after 16 weeks of niacin therapy [33].